Cilostazol, a phosphodiesterase III inhibitor: future perspectives in atherosclerosis.
da Rosa
Marcelo Pereira
MP
Instituto de Cardiologia do Rio Grande do Sul, FUC, Porto Alegre, RS, Brazil.
Baroni
Gislaine Verginia
GV
Portal
Vera Lúcia
VL
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D050197:Atherosclerosis / Q000188:drug therapy*; D000077407:Cilostazol; D054684:Cyclic Nucleotide Phosphodiesterases, Type 3; D006801:Humans; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D013777:Tetrazoles / Q000627:therapeutic use*
D010726:Phosphodiesterase Inhibitors; D013777:Tetrazoles; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D054684:Cyclic Nucleotide Phosphodiesterases, Type 3; D000077407:Cilostazol